Biotech Values

[RNsidersbuying]

INO 10.28 - how convenient for Citron to omit the White House Meeting including INO's Dr. Kim which should have been at the top of their DD priority list?

https://citronresearch.com/wp-content/uploads/2020/04/Inovio-Pharmaceuticals-Bad-Blood.pdf

Of all the 100% scams out there playing on this covid-bandwagon, Citron bash-shorts INO? Lost a large bit of respect for Citron...

https://www.whitehouse.gov/briefings-statements/remarks-president-trump-members-coronavirus-task-force-meeting-pharmaceutical-companies/

DR. KIM: Mr. President, Mr. Vice President, my name is Joseph Kim. I run a company called Inovio Pharmaceuticals out of Pennsylvania. We’re a proud American biotech company with R&D and manufacturing in California as well.

Inovio is the leader in coronavirus vaccine development in the world. We have a phase two product for related MERS coronavirus vaccine in phase two stage. When the new outbreak occurred, we applied our very innovative 21st century platform called DNA medicines platform to COVID-19. By getting just the DNA sequence of the virus, we were able to fully construct our vaccine within three hours. And we’ve been working on preclinical and preparation work with the help of the FDA in acceleration and really working very well together.

Our plan is to start the U.S.-based clinical trials for COVID-19 vaccine in April of this year; followed by, shortly thereafter, a trial in China, in South Korea. There are a lot more infections in those areas.

THE PRESIDENT: We can give you an area, too.

DR. KIM: (Laughs.)

THE PRESIDENT: No, we can. I mean, you take — you take a look at Seattle again.

DR. KIM: Absolutely.

THE PRESIDENT: We can give you an area.

DR. KIM: Absolutely.

THE PRESIDENT: If you don’t mind.

DR. KIM: We’ve been collaborating with U.S. agencies like DARPA, NIH. We’ve collaborated with Dr. Birx in HIV vaccines many, many years ago. With existing resources and capacity, by end of this year, Inovio could deliver about one million doses, but to scale — by end of this year — but to scale beyond that, we need your help, Mr. President. We need to work with you and your agencies, BARDA, and others to help us scale our vaccine to manufacture in America, to protect American public, also to lead the world in the vaccine development from America. Thank you very much.

THE PRESIDENT: No, thank you very much. You’ll have our help. Thank you.

Swing-trading INO and immediately writing high premium weekly calls...